F93F129: DEXTROSE INJECTION.
The DEXTROSE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: BAG, PLASTIC, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 80, primary_container_content_quantity: 100.000 MILLILITERS, active_medicament_medicinal_strength: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-384-1362, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | EACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE |
| primary_container_type | BAG, PLASTIC |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 80 |
| primary_container_content_quantity | 100.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | DEXTROSE INJECTION USP 100ML PLASTIC BAG |
| NSN | 6505-01-384-1362 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BAG, PLASTIC |
| SPECIAL FEATURES | EACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DEXTROSE INJECTION USP 100ML PLASTIC BAG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 80 |